ArticleBiomedicines2022

Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients.

Ken Kudura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.